We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MCHP:NASDAQMicrochip Technology Incorporated Analysis

Data as of 2026-05-29 - not real-time

$96.04

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Microchip Technology (MCHP) is trading just below its 20‑day simple moving average, comfortably above the 50‑ and 200‑day averages, which signals a bullish price trend. The Relative Strength Index sits in the upper‑mid range, while the MACD histogram is negative, indicating emerging bearish momentum, and volume has been on a decreasing trajectory, suggesting a potential short‑term consolidation. On the fundamentals side, the company posted a robust 35% year‑over‑year revenue growth, forward EPS of over $4 versus trailing EPS of $0.22, and a dividend yield near 2% backed by a very low payout ratio, reinforcing cash‑flow stability despite a high debt load.
Valuation metrics reveal a stark disconnect: the trailing P/E exceeds 400, far above the semiconductor industry average of around 40, and the discounted cash‑flow fair value sits roughly $30 below the current market price, implying the stock is significantly overvalued. Nonetheless, analysts maintain a “buy” consensus with a median target near $120, reflecting confidence in continued demand for MCHP’s embedded solutions and the upside potential relative to its current price.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering near the 20‑day SMA with bearish MACD divergence
  • Decreasing volume trend indicating weaker buying pressure
  • Support level just below current price providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong 35% revenue growth and accelerating earnings
  • Sustainable dividend with a low payout ratio
  • Analyst consensus “buy” and target price implying ~18% upside

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Significant valuation premium versus DCF fair value
  • High leverage (debt‑to‑equity) increasing financial risk
  • Secular demand for embedded and AI‑related semiconductor solutions

Key Metrics & Analysis

Financial Health

Revenue Growth35.10%
Profit Margin4.88%
P/E Ratio436.5
ROE3.40%
ROA2.23%
Debt/Equity87.72
P/B Ratio8.1
Op. Cash Flow$962.1M
Free Cash Flow$1.1B
Industry P/E40.9

Technical Analysis

TrendBullish
RSI58.7
Support$89.12
Resistance$105.91
MA 20$96.13
MA 50$82.04
MA 200$70.44
MACDBearish
VolumeDecreasing
Fear & Greed Index93.41

Valuation

Fair Value$65.88
Target Price$113.24
Upside/Downside17.91%
GradeOvervalued
TypeGrowth
Dividend Yield1.90%

Risk Assessment

Beta1.59
Volatility48.56%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.